Page 2 - Johan Dighed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan dighed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Dighed Today - Breaking & Trending Today

Karolinska Development's portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round -January 17, 2024 at 06:26 am EST

STOCKHOLM, SWEDEN January 17, 2024. Karolinska Development AB today announces that its portfolio company AnaCardio has received the second tranche of SEK 50 million, completing the previously. ....

Ann Helene Ljungstr , Viktor Drvota , Johan Dighed , Karolinska Institutet , Karolinska Development Ab Nasdaq Stockholm , Ab Health Ventures , Karolinska Development , Nasdaq Stockholm , Flerie Invest , Health Ventures , General Counsel ,

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Viktor Drvota , Johan Dighed , Karolinska Institutet , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Buda Health Clinic , National Center , Investment Fund , Drug Administration , Nasdaq Stockholm , Ossdsign Catalyst , Spinal Disorders , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93%. ....

Viktor Drvota , Johan Dighed , Karolinska Institutet , Investment Fund , Buda Health Clinic , Drug Administration , National Center , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Nasdaq Stockholm , Ossdsign Catalyst , Spinal Disorders , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93% spinal fusion rate at 12 months as assessed with CT by independent radiological review after surgery with the novel nanosynthetic bone graft OssDsign Catalyst. The data, that has been submitted to a peer-reviewed scientific journal, indicates that the use of OssDsign Catalyst lead ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Investment Fund , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Buda Health Clinic , Drug Administration , National Center , Nasdaq Stockholm , Ossdsign Catalyst , Spinal Disorders , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,

Karolinska Development's portfolio company OssDsign expects fourth-quarter revenues to exceed market estimates

STOCKHOLM, SWEDEN, December 6, 2023. Karolinska Development AB announces that the portfolio company OssDsign expects revenues for the fourth quarter of 2023 to exceed market expectations. Preliminary. ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Drug Administration , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Investment Fund , Nasdaq Stockholm , Ossdsign Catalyst , Ossdsign Cranial , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,